Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Feb 28, 2025
Ticker Group $ALB, $WWR, $LAC, $CBAT, $PLL, $LTHM: Impressive +6.39% Weekly Performance Surge in Lithium Companies

Ticker Group $ALB, $WWR, $LAC, $CBAT, $PLL, $LTHM: Impressive +6.39% Weekly Performance Surge in Lithium Companies

Robots for this industry :
Swing trader: Volatility Balanced Strategy v.2 (TA) - 30-day Annualized Return +36%
Swing Trader for Beginners: Exits from Low Volatility to Explosive Movements (TA&FA) - 30-day Annualized Return +25%

The lithium market has been on a rollercoaster ride recently, with a surge in performance followed by ominous indicators of a downturn. In the past week, lithium companies experienced a significant increase of +10.02% in their performance, grabbing the attention of investors. However, a closer look reveals concerning signs in the market, with key indicators suggesting a negative outlook. In this article, we will delve into the current state of the lithium market, analyzing key stocks in the sector and the factors driving their performance.

The Lithium Theme and Tickers: Lithium, a versatile chemical element with applications ranging from heat-resistant glass to batteries, has driven the growth of companies involved in its exploration and development. The group of tickers we are examining in this theme includes ALB (Albemarle Corporation), WWR (Westwater Resources, Inc.), LAC (Lithium Americas Corp.), CBAT (CBAK Energy Technology Inc.), PLL (Piedmont Lithium Limited), and LTHM (Livent Corporation). These companies are at the forefront of the lithium market, each contributing to the industry in its unique way.

Market Capitalization: The average market capitalization across the lithium theme stands at a substantial $4.1 billion. However, there is a wide range within the group, with ALB holding the highest valuation at $18.8 billion, while WWR is valued at a much lower $32 million. This variation in market cap reflects the diversity in the size and scale of operations within the lithium sector.

Price Movements: Recent price movements in the lithium market have been intriguing. On a weekly basis, the average price growth across all lithium stocks was a robust 6.39%. However, over the past month, the market saw an average monthly price decline of -5.27%, and over the quarter, it witnessed a more substantial drop of -15.37%. Among the tickers in our group, LAC experienced an impressive price growth of 71.32%, while WWR faced a notable decline of -11.8%.

Volume Trends: Trading volumes have been a mixed bag for lithium stocks. On a weekly basis, the average volume growth across all stocks was -73.2%. Over the month, the average monthly volume growth stood at -26.51%, and for the quarter, it was -53.89%. Interestingly, some outliers caught our attention. For instance, CBAK Energy Technology saw a record-breaking daily growth of 316% of the 65-Day Volume Moving Average on August 16th. Similarly, Westwater Resources recorded a remarkable daily growth of 112% of the 65-Day Volume Moving Average on August 2nd.

Individual Ticker Analysis:

  1. ALB (Albemarle Corporation):

    • ALB recently saw its Moving Average Convergence Divergence Histogram (MACD) turn negative, signaling a potential bearish trend.
    • Historical data shows that in 32 out of 44 instances where the MACD turned negative, the stock moved lower, with a 73% probability.
    • The current price of ALB is $155.68, which is below the lowest resistance line found by AI.
  2. LTHM (Livent Corporation):

    • LTHM's 50-day Moving Average crossed bearishly below its 200-day moving average on September 15, 2023, indicating a long-term bearish trend.
    • The current price of LTHM is $16.69, which is below the lowest support line found by AI.
  3. LAC (Lithium Americas Corp.):

    • LAC's Aroon Indicator triggered a bullish signal on September 26, 2023.
    • When the AroonUp green line is above 70 while the AroonDown red line is below 30, it suggests a bullish move.
    • Historical data indicates an 87% chance of a higher move in the days following this signal.

Summary: Despite the recent surge in performance, the lithium market faces headwinds, as indicated by various metrics and individual stock analyses. The negative outlook is a cause for concern, and investors should exercise caution. It's essential to monitor these key indicators closely to make informed decisions in this dynamic market. Lithium, with its critical role in various industries, will continue to be a significant sector to watch, but vigilance and careful analysis are paramount in these uncertain times.

Related Ticker: ALB, WWR, LAC, CBAT, PLL, LTH

Contributor

Dem Sem's AvatarDem Sem|Expert

ALB's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for ALB moved out of overbought territory on August 25, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 instances where the indicator moved out of the overbought zone. In 34 of the 39 cases the stock moved lower in the days that followed. This puts the odds of a move down at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALB as a result. In 62 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.

The Moving Average Convergence Divergence Histogram (MACD) for ALB turned negative on September 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 37 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

ALB moved below its 50-day moving average on September 09, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for ALB crossed bullishly above the 50-day moving average on August 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.

Following a +2.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALB advanced for three days, in 245 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

ALB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 183 of 231 cases where ALB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. ALB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.725) is normal, around the industry mean (6.603). ALB's P/E Ratio (435.259) is considerably higher than the industry average of (36.348). Projected Growth (PEG Ratio) (0.959) is also within normal values, averaging (2.079). Dividend Yield (0.014) settles around the average of (0.020) among similar stocks. P/S Ratio (2.525) is also within normal values, averaging (62.734).

The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.11B. The market cap for tickers in the group ranges from 47 to 214.92B. LIN holds the highest valuation in this group at 214.92B. The lowest valued company is GTBT at 47.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -2%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 6%. YMAT experienced the highest price growth at 22%, while ASPI experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 57
Price Growth Rating: 57
SMR Rating: 78
Profit Risk Rating: 82
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
ALB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of specialty polymers, chemicals and related products

Industry ChemicalsSpecialty

Profile
Details
Industry
Chemicals Specialty
Address
4250 Congress Street
Phone
+1 980 299-5700
Employees
7800
Web
https://www.albemarle.com
Interact to see
Advertisement
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.
NBIS shares surged approximately +10% in premarket trading on March 11, 2026, from a prior close of $96.32. The primary catalyst is the imminent addition of Nebius Group to the Bloomberg 500 (B500) Index, effective prior to the open of trading on Thursday, March 12, 2026.
ORCL shares surged approximately +10.49% in Wednesday's premarket session, trading around $165.07 versus Tuesday's closing price of $149.40. The primary catalyst is Oracle's Q3 FY2026 earnings beat, with adjusted EPS of $1.79 vs. the $1.70 consensus estimate, and revenue of $17.2 billion topping the $16.92 billion forecast.
Shares of AngloGold Ashanti plc (AU) are down approximately 5.00% in early trading on March 11, 2026, falling from a prior close of $108.26 to around $102.85. The primary driver is a renewed pullback in gold prices, which has weighed heavily on gold mining equities across the board.
HMY shares are trading down approximately 13% in early session trading on March 11, 2026, following the release of the company's H1 FY26 interim results. Revenue of R44.4 billion (~US$2.6 billion) missed analyst consensus estimates of R47.56 billion, a significant shortfall that spooked investors.
FICO fell over 9% today, extending a multi‑week downtrend that has already knocked the stock more than 7% lower since its last earnings update. The decline comes despite strong recent financial results, including double‑digit revenue growth, expanding margins, and repeated earnings beats.
RERE fell roughly 10% today, giving back a portion of its strong gains over the past year and month, as traders reacted to fresh earnings and guidance. The company delivered robust Q4 2025 results, with revenue growth near 30% year over year and earnings per share ahead of consensus estimates, underscoring continued operational momentum.
Top hedge funds like Millennium, Citadel, and Bridgewater showed limited direct accumulation of penny stocks in Q4 2025 13F filings, but rotations into biotech, energy, and defense sectors highlight indirect interest in low-priced plays under $5. New entries and increased positions focused on volatile sectors like biotech (e.g., ABCL) and energy (e.g., AMPY), with full exits from overvalued names signaling a hunt for undervalued pennies amid market uncertainty.